Filing Details

Accession Number:
0001209191-21-049087
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-02 17:06:14
Reporting Period:
2021-07-29
Accepted Time:
2021-08-02 17:06:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
822370 Emmaus Life Sciences Inc. EMMA Pharmaceutical Preparations (2834) 870419387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517691 Yutaka Niihara 21250 Hawthorne Blvd.
Suite 800
Torrance CA 90503
Chairman And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2021-07-29 1,000 $1.50 10,807,371 No 4 P Direct
Common Stock, $0.001 Par Value Acquisiton 2021-07-30 500 $1.50 10,807,871 No 4 P Direct
Common Stock, $0.001 Par Value Acquisiton 2021-08-02 2,600 $1.47 10,810,471 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 92,794 Indirect By Hope International Hospice, Inc.
Common Stock, $0.001 Par Value 63,000 Indirect By Soomi Niihara
Footnotes
  1. The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
  2. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
  3. Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.